HMP Global November 25, 2024

In this interview, Rebecca Maniago, PharmD, discusses the complexities of implementing custom clinical pathways, emphasizing the need for clear goals, robust resources, and ongoing updates, while highlighting the pivotal role of pharmacists in pathway development, regimen management, and enhancing patient outcomes.

Transcript:

Rebecca Maniago, PharmD: My name is Rebecca Maniago. I’m an oncology pharmacist by background, and I’ve worked at Flatiron Health for 5 years now, leading the clinical team that’s involved in the development of our clinical decision support tool called Flatiron Assist. Our application is built on NCCN guidelines; however we allow for local customization, which means I have had the opportunity to work with several customers that have built custom pathways and ultimately integrated those into...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Pharma, Pharma / Biotech, Trends
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
Healthcare supply chain, pharmacy costs to rise in 2025: report
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA
STAT+: DeepSeek signals China’s rising influence in AI — and AI drug development
Is 2025 the Chinese Year of BioPharma?

Share This Article